- Home
- Medical books
- Clinical pharmacology lecture
- Drugs that should be avoided or used with caution during pregnancy
Drugs that should be avoided or used with caution during pregnancy
Most manufacturers recommend avoiding (or avoiding unless the potential benefit outweighs the risk); Ketorolac is contraindicated during pregnancy, labour, and delivery.
Stages in pregnancy
(1) the first 3 months
(2) the next 3 months
(3) Last 3 months
Drugs/drug classes (at risk episodes) |
Comment |
Acarbose |
The manufacturer recommends avoiding the use |
Acyclovir |
There is not much experience with this drug. Manufacturers recommend using only when potential benefits outweigh risks; the low amount of drug absorbed from related pharmaceutical products |
Albendazole |
The manufacturer warns of teratogenicity in animal studies |
amantadine |
Avoid use; drug toxicity in animal studies |
Androgen (1, 2, 3) |
Causing virilization in female foetuses |
Aspirin (3) |
Decreased platelet function and risk of bleeding; delaying the onset of labour and prolonging labour and causing massive blood loss. Avoid pain relievers if possible, for the last few weeks (low doses may be harmless); In high doses, it causes closure of the ductus arteriosus of the foetus in utero and may lead to a prolonged increase in pulmonary arterial pressure in the neonate; causes kernicterus in neonates with jaundice |
Barbiturate (3) |
Smoking withdrawal symptoms in infants |
Benzodiazepine |
Avoid if possible (in late pregnancy or during delivery, high doses can cause hypothermia, hypotonia and respiratory depression in the new-born); Neonatal withdrawal syndromes may occur after prolonged use |
Vaccines (live)
(1) |
Theoretically, there is a risk of birth defects; but if the need for vaccination is greater than the possible risk to the foetus, it is still used |
MMR (Measles, Mumps, and Rubella) and measles-rubella vaccines should be avoided. |
|
Cephalosporin |
Don't know the harm |
Chloramphenicol (3) |
Causing "grey syndrome" in new-borns |
Cimetidine |
Manufacturer recommends avoiding unless necessary |
Clarithromycin |
Harm is unknown but the manufacturer advises to avoid unless the benefit outweighs the risk |
Clindamycin |
Don't know the harm |
Corticosteroid |
Use only when benefits outweigh risks, for example in the treatment of asthma; Systematic high doses may cause foetal and neonatal adrenal suppression; risk of intrauterine growth retardation with prolonged or repeated systemic therapy; continuing to administer corticosteroids to the mother during delivery; Close monitoring is required if |
Co-trimoxazole (1) (3) |
Theoretically teratogenic (antibacterial, folate antagonists) Causes neonatal haemolysis and methemoglobinemia; No risk of nuclear jaundice has been observed in neonates |
Cyclophosphamide |
Avoid (manufacturer recommends effective birth control during and for at least 3 months after treatment with this medicine for both men and women) |
Ergotamine |
The effect of assisted childbirth on the uterus of pregnant women |
Heparin (1, 2, 3) |
There are reports of osteoporosis after prolonged use |
Mebendazole |
The manufacturer recommends toxicity in animal studies |
Metformin (1, 2, 3) |
Avoid using |
Methotrexate |
Avoid (teratogenic; may reduce fertility during treatment but is reversible); The manufacturer recommends effective contraception during and for at least 6 months after taking the pill for both men and women |
Metoclopramide |
The harmful effects are unknown, but the manufacturer recommends using it only for force majeure reasons |
Metronidazole |
The manufacturer recommends avoiding high doses |
Naloxone |
The manufacturer recommends using only when the benefits outweigh the risks |
aminoglycoside group (2, 3) |
Damage to the auditory or vestibular nerve; highest risk with streptomycin; There may be very little risk with gentamicin and tobramycin but should be avoided unless necessary (if necessary, plasma concentrations should be monitored). |
Nicotine (1, 2, 3) |
Avoid using |
Nitrofurantoin (3) |
May cause neonatal haemolysis if used near the time of delivery |
Omeprazole |
The manufacturer recommends toxicity in animal studies |
Paracetamol |
Don't know the harm |
Penicillin |
Don't know the harm |
Phenytoin (1, 3) |
Congenital malformations described (screening recommended); adequate maternal folate supplementation (eg, folic acid 5mg/day). Tendency to neonatal bleeding - vitamin K prophylaxis should be provided to the mother before delivery (and also to the new-born) Care should be taken when interpreting plasma concentrations – binding may be reduced but free (effective) rate unchanged. |
Propylthiouracil (2, 3) |
Causes goitre and hypothyroidism in new-borns |
Quinine (1, 2, 3) |
High doses are teratogenic; But in patients with malaria, the benefits of treatment outweigh the risks |
Quinolones (1, 2, 3) |
Avoid - there was joint disease in animal studies |
Ranitidine |
The manufacturer advises avoiding unless necessary |
Rifampicin (1) (3) |
Manufacturers recommend that high doses are teratogenic in animal studies May increase risk of neonatal bleeding |
Alcohol (1, 2)
(3) |
If taken daily, it will cause teratogenicity (foetal alcohol syndrome) and may cause developmental delay; it is safe to drink occasionally and drink sparingly Smoking withdrawal syndrome may occur in children of alcoholic mothers |
Sulphonamide (3) |
Causes neonatal haemolysis and methemoglobinemia; No high risk of neonatal jaundice has been found |
Sulphonyl (3) |
Causes neonatal hypoglycaemia; insulin is commonly substituted in all diabetes medications; If taking oral drugs, treatment must be stopped immediately at least 2 days before delivery |
Tetracycline (1) (3) |
Affects skeletal development in animal studies. Causes discolouration of tooth enamel; Maternal liver toxicity if high doses are taken orally |
Theophylline (3) |
There are reports of stimulant effects and apnoea |
Beta-blockers |
May inhibit foetal growth in utero, cause hypoglycaemia and bradycardia; higher risk shown in severe hypertension |
Oral anticoagulants (1, 2, 3) |
Causes deformities; foetal and neonatal haemorrhage |
Non-steroidal anti-inflammatory drugs (NSAIDs) (3) |
Most manufacturers recommend avoiding (or avoiding unless the potential benefit outweighs the risk); Ketorolac is contraindicated during pregnancy, labour and delivery. If used regularly, it causes closure of the foetal ductus arteriosus in utero and may cause persistent pulmonary hypertension in the neonate. Delays the onset of labour and prolongs labour. |
Anaesthetics, general (3) |
Causes neonatal respiratory depression |
Anaesthesia, topical (3) |
In large doses, neonatal respiratory depression, hypotonia, and bradycardia after lateral cervical or epidural obstruction; neonatal methemoglobinemia with prilocaine and procaine |
Opioids (3) |
neonatal respiratory depression; induce withdrawal effects in the neonates of drug-dependent mothers; causing gastric retention and aspiration pneumonia (inhalation pneumonia) in the mother during labour and delivery |
Diuretic (1)
(3) |
Do not use to treat high blood pressure during pregnancy Manufacturers recommend avoiding acetazolamide and torsemide Thiazides can cause neonatal thrombocytopenia |
Metabolic steroids |
Causing virilization for female foetuses |
Angiotensin-converting enzyme inhibitors (1, 2, 3) |
Avoid use; harmful effects on the foetus, blood pressure and renal function of the neonate; can also cause skull defects and oligohydramnios; have drug poisoning through animal studies |
Trimethoprim (1) |
Theoretically teratogenic (folate antagonist) |
Vancomycin |
The manufacturer advises avoidance unless the potential therapeutic benefit outweighs risk - little other information currently available |
Vitamin A (1) |
Overdose can be teratogenic. |